Awarded
Suministro del medicamento exclusivo: Ravulizumab (ULTOMIRIS).
Original language: Spanish
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- ALEXION PHARMA SPAIN, S.L
- Contract value
- €2,603,216
- Bids received
- 1
- Published
- 8 Sept 2026
- Awarded
- 27 May 2026
- Contract start
- 27 May 2026
- Contract end
- 9 Jun 2027estimated
- Region
- Madrid